Recalls / Class II
Class IID-0049-2025
Product
Guaifenesin Dextromethorphan Syrup, 200 mg/20mg per 10 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7135-72
- Affected lot / code info
- Lot #: C00128, Exp. Date 04/2025; C00146, Exp.Date 07/2025
Why it was recalled
Failed Impurity/Degradation Specifications
Recalling firm
- Firm
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 341 Mason Rd, N/A, La Vergne, Tennessee 37086-3606
Distribution
- Quantity
- N/A
- Distribution pattern
- Nationwide within the United States
Timeline
- Recall initiated
- 2024-11-07
- FDA classified
- 2024-11-18
- Posted by FDA
- 2024-11-27
- Terminated
- 2026-03-05
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0049-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.